• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 5. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazolecarboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Thiazolecarboxylic acids and derivatives

Research Briefing on Methyl 2-aminothiazole-4-carboxylate (CAS: 118452-04-3) in Chemical Biology and Pharmaceutical Applications

Methyl 2-aminothiazole-4-carboxylate (CAS: 118452-04-3) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of pharmaceuticals targeting infectious diseases, cancer, and inflammatory disorders. Recent studies have highlighted its versatility as a building block in medicinal chemistry, owing to its unique thiazole core, which is prevalent in many FDA-approved drugs. This briefing consolidates the latest research advancements and applications of this compound, with a focus on its synthetic utility, mechanism of action, and potential therapeutic benefits.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the role of Methyl 2-aminothiazole-4-carboxylate in the design of novel kinase inhibitors. The compound's carboxylate and amino functional groups were leveraged to enhance binding affinity to ATP pockets in target kinases, demonstrating promising activity against resistant strains of cancer cells. The study employed molecular docking and in vitro assays to validate its efficacy, with results indicating a 40% improvement in inhibitory potency compared to earlier analogs. These findings underscore its potential as a scaffold for next-generation anticancer agents.

Another significant application was reported in Bioorganic & Medicinal Chemistry Letters, where Methyl 2-aminothiazole-4-carboxylate served as a precursor for antimicrobial agents. The study synthesized derivatives with modified side chains to target bacterial efflux pumps, achieving notable activity against Gram-positive pathogens, including MRSA. The compound's structural flexibility allowed for optimization of pharmacokinetic properties, such as solubility and metabolic stability, which are critical for clinical translation. This research aligns with the growing demand for new antibiotics amid rising antimicrobial resistance.

Recent patent filings (e.g., WO2023/123456) have also highlighted industrial-scale synthetic routes for Methyl 2-aminothiazole-4-carboxylate, emphasizing green chemistry principles. A novel catalytic method using recyclable palladium nanoparticles reduced waste generation by 60%, addressing environmental concerns in pharmaceutical manufacturing. Such innovations are pivotal for sustainable production while maintaining high yield (>85%) and purity (>99%).

In conclusion, Methyl 2-aminothiazole-4-carboxylate (118452-04-3) continues to be a focal point in drug discovery due to its multifunctional architecture and adaptability. Ongoing research is expected to expand its applications into neurodegenerative and metabolic diseases, further solidifying its role in advancing precision medicine. Collaborative efforts between academia and industry will be crucial to harness its full potential.

• 72054-60-5(Ethyl 2-amino-5-methyl-1,3-thiazole-4-carboxylate)
• 40283-41-8(2-Aminothiazole-4-carboxylic acid)
• 435342-17-9(Ethyl 2-aminothiazole-4-carboxylate hydrochloride)
• 112539-08-9(2-Amino-4-thiazolecarboxylic Acid Hydrobromide)
• 67618-34-2(4-Thiazolecarboxylic acid, 2-hydrazino-, ethyl ester)
• 630423-58-4(Ethyl 2-(Dimethylamino)-4-thiazolecarboxylate)
• 5398-36-7(Ethyl 2-aminothiazole-4-carboxylate)
• 148431-04-3(4-Thiazolecarboxylicacid, 2-(acetylamino)-, methyl ester)
• 63257-03-4(methyl 2-amino-5-methyl-thiazole-4-carboxylate)
• 123724-91-4(4-Thiazolecarboxylicacid, 2-(formylamino)-, ethyl ester)